Conn. Jumps Into Zyprexa Fray With Lawsuit

Law360, New York (March 7, 2008, 12:00 AM EST) -- Eli Lilly & Co. was hit with a new lawsuit Thursday over its controversial anti-psychotic drug Zyprexa, this time filed by the state of Connecticut.

Echoing allegations that Eli Lilly already faces in a massive multidistrict litigation in the Eastern District of New York, Connecticut alleges that Eli Lilly first overcharged for the drug and then marketed it through a fraudulent campaign that concealed its possible link to diabetes.

The lawsuit also alleges that the company engaged in racketeering with medical marketing firms and doctors in...
To view the full article, register now.

Documents

Related

Sections

Case Information

Case Title

In re: Zyprexa Products Liability Litigation


Case Number

1:04-md-01596

Court

New York Eastern

Nature of Suit

Personal Inj. Prod. Liability

Judge

Jack B. Weinstein

Date Filed

April 19, 2004

Law Firms

Companies

Government Agencies

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.